The Federal Court Appeals Decision Will Cost You

On Tuesday, a federal appeals court ruled that biosimilar drug makers must always notify their brand-name rivals six months before launching biologic medicines, causing delay in competition for pricey drugs. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.